In vitro labeling of mesenchymal stem cells with superparamagnetic iron oxide by means of microbubble-enhanced us exposure: Initial experience

Radiology

Volumn 253, Issue 1, 2009, Pages 153-159

  Liu, Zai Yi ^a   Wang, Ying ^b   Liang, Chang Hong ^a   Li, Xiao Hong ^c   Wang, Guang Yi ^a   Liu, Hong Jun ^a   Li, Yan ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c Guangdong Provincial Cardiovascular Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN; SONOVUE; SUPERPARAMAGNETIC IRON OXIDE; CONTRAST AGENT BR1; CONTRAST MEDIUM; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACHINE; MESENCHYMAL STEM CELL; MICROBUBBLE; OSTEOCYTE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND; ULTRASOUND TRANSDUCER; CELL CULTURE; CELL SURVIVAL; ECHOGRAPHY; FEASIBILITY STUDY; METABOLISM; STAINING;

CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CONTRAST MEDIA; FEASIBILITY STUDIES; HUMANS; MESENCHYMAL STEM CELLS; PHOSPHOLIPIDS; STAINING AND LABELING; SULFUR HEXAFLUORIDE;

EID: 70350517461     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2531081974     Document Type: Article

References (48)

1. Barnett BP, Arepally A, Karmarkar PV, et al. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007;13:986-991.
2. Zhang Z, Mascheri N, Dharmakumar R, Li D. Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease. Cytotherapy 2008;10:575-586.
3. Sun JH, Teng GJ, Ju SH, Ma ZL, Mai XL, Ma M. MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure. Cell Transplant 2008;17:279-290.
4. Neri M, Maderna C, Cavazzin C, et al. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells 2008;26:505-516.
5. Hoehn M, Kustermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002;99:16267-16272.
6. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-487.
7. Bos C, Delmas Y, Desmouliere A, et al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004;233:781-789.
8. Ittrich H, Lange C, Togel F, et al. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 2007;25:1179 -1191.
9. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004;17:513-517.
10. Zhang C, Wangler B, Morgenstern B, et al. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Langmuir 2007;23:1427-1434.
11. Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104:1217-1223.
12. Bauer M, Kristensen BW, Meyer M, et al. Toxic effects of lipid-mediated gene transfer in ventral mesencephalic explant cultures. Basic Clin Pharmacol Toxicol 2006;98:395-400.
13. Arbab AS, Yocum GT, Rad AM, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18:553-559.
14. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005;54:769-774.
15. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001;48:232-248.
16. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006;41:354-362.
17. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 2006;60:324-330.
18. Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol 2007;93:354-362.
19. Guo DP, Li XY, Sun P, et al. Ultrasound-targeted microbubble destruction improves the low density lipoprotein receptor gene expression in HepG2 cells. Biochem Biophys Res Commun 2006;343:470-474.
20. Farrell E, Wielopolski P, Pavljasevic P, et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 2008;369:1076-1081.
21. Choi D, Kim JH, Lim M, et al. Hepatocyte-like cells from human mesenchymal stem cells engrafted in regenerating rat liver tracked with in vivo magnetic resonance imaging. Tissue Eng Part C Methods 2008;14:15-23.
22. Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci 2006;47:558-564.
23. Zong Y, Wan M, Wang S, Zhang G. Optimal design and experimental investigation of surfactant encapsulated microbubbles. Ultrasonics 2006;44(suppl 1):e119-e122.
24. Zhao YZ, Luo YK, Liang HD, et al. Comparing transfection efficiency and safety for antisense oligodeoxyribonucleotide between phospholipids-based microbubbles and liposomes. J Drug Target 2006;14:687-693.
25. Takahashi T, Matsubara H. New targeted angiogenic strategy: bursting bubbles. Circ Res 2007;101:232-233.
26. Wu J, Nyborg WL. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008;60:1103-1116.
27. O'Neill BE, Li KC. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int J Hyperthermia 2008;24:506-520.
28. Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008;60:1153-1166.
29. Newman CM, Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 2007;14:465-475.
30. Li X, Yu X, Lin Q, et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol 2007;42:295-303.
31. Sun R, Dittrich J, Le-Huu M, et al. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005;40:504-513.
32. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-1858.
33. Wang Y, Xu HX, Lu MD, Tang Q. Expression of thymidine kinase mediated by a novel nonviral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells. World J Gastroenterol 2008;14:224-230.
34. Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 2007;243:467-474.
35. Schafer R, Kehlbach R, Wiskirchen J, et al. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007;244:514-523.
36. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005;235:155-161.
37. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003;229:838-846.
38. Stride E, Porter C, Prieto AG, Pankhurst Q. Enhancement of microbubble mediated gene delivery by simultaneous exposure to ultrasonic and magnetic fields. Ultrasound Med Biol 2009;35:861-868.
39. Mani V, Adler E, Briley-Saebo KC, et al. Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med 2008;60:73-81.
40. Fraser JK, Zhu M, Wulur I, Alfonso Z. Adipose-derived stem cells. Methods Mol Biol 2008;449:59-67.
41. Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol 2008;34:425-434.
42. Akita H, Harashima H. Nonviral gene delivery. Contrib Nephrol 2008;159:13-29.
43. Guo H, Leung JC, Chan LY, et al. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat. Gene Ther 2007;14:1712-1720.
44. Korosoglou G, Hardt SE, Bekeredjian R, et al. Ultrasound exposure can increase the membrane permeability of human neutrophil granulocytes containing microbubbles without causing complete cell destruction. Ultrasound Med Biol 2006;32:297-303.
45. Tai JH, Foster P, Rosales A, et al. Imaging islets labeled with magnetic nanoparticles at 1.5 tesla. Diabetes 2006;55:2931-2938.
46. Yang F, Li L, Li Y, Chen Z, Wu J, Gu N. Superparamagnetic nanoparticle-inclusion microbubbles for ultrasound contrast agents. Phys Med Biol 2008;53:6129-6141.
47. Dijkmans PA, Juffermans LJ, Musters RJ, et al. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr 2004;5:245-256.
48. Lai CY, Wu CH, Chen CC, Li PC. Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability. Ultrasound Med Biol 2006;32:1931-1941.